GYDECATNCT05924217
Gynecology Beyond Gender: Cervical Cancer Screening in Transgender Men in France
StatusCompleted
PhaseNot specified
Primary completion
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 7 words Show 4 more changesShow less
- Trial completed
- Final enrollment: 75 participants (planned 300)
- Study completion date changed from estimate of Jun 30, 2026 to Dec 8, 2025
- Secondary endpoints: details revised at 1 of 1 entry
- Minor Trial status: Recruiting to Active, Not Recruiting
- Primary completion date changed from estimate of Dec 31, 2024 to Jan 1, 2025
- Study completion date: Dec 31, 2024 to Jun 30, 2026
- Site details revised
- Notable Trial status: Not Yet Recruiting to Recruiting
- Start date changed from estimate of Sep 1, 2023 to Jan 2, 2024
- Site details revised
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
prevalence of transgender men who have ever been screened for cervical cancer in their lifetime
Timeframe: At study entry, basline (no follow-up)
Secondary (1)
prevalence of transgender men who feel concerned about cervical cancer screening
Arms and interventions
Other: Survey questionnaire
Sites
1 site in 1 country
- CHU de NîmesNîmes, France